Schedule 13G ownership disclosure

Nurix Therapeutics Inc

Common Stock · CUSIP: 67080M103

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Wellington Management Group LLP

    Shares: 3,188,742.00 · Class: 4.2%

  • Wellington Group Holdings LLP

    Shares: 3,188,742.00 · Class: 4.2%

  • Wellington Investment Advisors Holdings LLP

    Shares: 3,188,742.00 · Class: 4.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-25-000191
Form type
SCHEDULE 13G/A
Filer
Nurix Therapeutics, Inc.
CIK
CIK 1549595
Filed
May 12, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub